Congruence
Company Information
Congruence Therapeutics develops computational drug discovery technologies designed to identify therapies targeting protein misfolding diseases. The company uses machine learning and structural biology to discover small molecule treatments.
Industry Focus and Technologies
AI drug discovery, protein misfolding therapeutics, computational biology
Location
Montreal, Quebec, Canada
Company Size and Stage
Products, Platforms or Focus Areas
AI drug discovery, protein misfolding therapeutics, computational biology